Drug Delivery Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application (Cancer, Cardiovascular, Diabetes, Infectious Diseases, and Other Applications), By Route of Administration (Injectable, Topical, Ocular, and Others), By End User (Hospitals, Ambulatory Surgical Centers, and Others), By Region and Competition, 2020-2030F

November 2025 | 185 pages | ID: DD8FE4EACEF5EN
TechSci Research

Abstracts

The Global Drug Delivery Devices Market , valued at USD 261.32 Billion in 2024, is projected to experience a CAGR of 7.91% to reach USD 412.66 Billion by 2030. Drug delivery devices are specialized medical technologies engineered to administer therapeutic substances to the body in a controlled and optimized manner, encompassing various routes such as injectable, oral, transdermal, and inhalation systems. The market's expansion is significantly driven by the increasing global prevalence of chronic diseases requiring long-term medication management and a growing demand for patient-centric care solutions, including self-administration.

Key Market Drivers

The increasing global burden of chronic diseases significantly propels the demand for drug delivery devices, as effective long-term management of conditions like diabetes, cardiovascular diseases, and cancer necessitates reliable and often specialized administration methods. This demographic shift towards an older population with higher rates of comorbidities fuels the need for advanced solutions capable of precise dosing and improved patient adherence across various care settings, including home care. According to the World Health Organization's 'Noncommunicable diseases' fact sheet, in 2021, 43 million people died from an NCD, accounting for 75% of non-pandemic-related deaths globally, underscoring the widespread need for effective therapeutic interventions delivered efficiently via modern devices.

Key Market Challenges

The complex and evolving regulatory landscape across different regions presents a significant impediment to the growth of the Global Drug Delivery Devices Market. Varying requirements for product development, clinical trials, and post-market surveillance introduce substantial unpredictability and complexity for manufacturers. This intricacy often leads to extended approval timelines and increased development expenditures, particularly for innovative combination products that integrate drugs and devices.

Key Market Trends

The rapid expansion of home-based and self-administration devices marks a transformative shift in healthcare delivery, enabling patients to manage treatments independently beyond conventional clinical settings. This evolution is primarily driven by growing demand for convenience, cost efficiency, and improved treatment adherence, particularly in chronic disease management. These solutions include user-friendly technologies such as pre-filled syringes, auto-injectors, and patch pumps, which simplify drug administration and improve the overall patient experience. Reflecting this structural change, MedTech Europe projects that the home-care segment will grow at a compound annual growth rate of 12.4% within the European medical devices market from 2025 to 2033, highlighting the accelerating transition toward decentralised care models. This momentum is further reinforced by strategic investments from leading manufacturers; for instance, Medtronic expanded 11 production lines for insulin pumps in Ireland in 2023, demonstrating its commitment to scaling capacity in response to rising demand for self-administered diabetes management solutions.

Key Market Players

• Pfizer Inc.
• Novartis AG
• F. Hoffmann-La Roche Ltd
• Johnson and Johnson
• Bayer AG
• Becton, Dickinson and Company
• Altaris Capital Partners, LLC
• Holozymes Inc. (Antares Pharma Inc.)
• GlaxoSmithKline PLC
• Teva Pharmaceutical Industries Ltd

Report Scope:

In this report, the Global Drug Delivery Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Drug Delivery Devices Market , By Application:
• Cancer
• Cardiovascular
• Diabetes
• Infectious Diseases
• Other Applications
• Drug Delivery Devices Market , By Route of Administration:
• Injectable
• Topical
• Ocular
• Others
• Drug Delivery Devices Market , By End User:
• Hospitals
• Ambulatory Surgical Centers
• Others
• Drug Delivery Devices Market , By Region:
• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Drug Delivery Devices Market .

Available Customizations:

Global Drug Delivery Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Contents

1. PRODUCT OVERVIEW

1.1. Market Definition
1.2. Scope of the Market
  1.2.1. Markets Covered
  1.2.2. Years Considered for Study
  1.2.3. Key Market Segmentations

2. RESEARCH METHODOLOGY

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. EXECUTIVE SUMMARY

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. VOICE OF CUSTOMER

5. GLOBAL DRUG DELIVERY DEVICES MARKET OUTLOOK

5.1. Market Size & Forecast
  5.1.1. By Value
5.2. Market Share & Forecast
  5.2.1. By Application (Cancer, Cardiovascular, Diabetes, Infectious Diseases, Other Applications)
  5.2.2. By Route of Administration (Injectable, Topical, Ocular, Others)
  5.2.3. By End User (Hospitals, Ambulatory Surgical Centers, Others)
  5.2.4. By Region
  5.2.5. By Company (2024)
5.3. Market Map

6. NORTH AMERICA DRUG DELIVERY DEVICES MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Application
  6.2.2. By Route of Administration
  6.2.3. By End User
  6.2.4. By Country
6.3. North America: Country Analysis
  6.3.1. United States Drug Delivery Devices Market Outlook
    6.3.1.1. Market Size & Forecast
      6.3.1.1.1. By Value
    6.3.1.2. Market Share & Forecast
      6.3.1.2.1. By Application
      6.3.1.2.2. By Route of Administration
      6.3.1.2.3. By End User
  6.3.2. Canada Drug Delivery Devices Market Outlook
    6.3.2.1. Market Size & Forecast
      6.3.2.1.1. By Value
    6.3.2.2. Market Share & Forecast
      6.3.2.2.1. By Application
      6.3.2.2.2. By Route of Administration
      6.3.2.2.3. By End User
  6.3.3. Mexico Drug Delivery Devices Market Outlook
    6.3.3.1. Market Size & Forecast
      6.3.3.1.1. By Value
    6.3.3.2. Market Share & Forecast
      6.3.3.2.1. By Application
      6.3.3.2.2. By Route of Administration
      6.3.3.2.3. By End User

7. EUROPE DRUG DELIVERY DEVICES MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Application
  7.2.2. By Route of Administration
  7.2.3. By End User
  7.2.4. By Country
7.3. Europe: Country Analysis
  7.3.1. Germany Drug Delivery Devices Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Application
      7.3.1.2.2. By Route of Administration
      7.3.1.2.3. By End User
  7.3.2. France Drug Delivery Devices Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Application
      7.3.2.2.2. By Route of Administration
      7.3.2.2.3. By End User
  7.3.3. United Kingdom Drug Delivery Devices Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Application
      7.3.3.2.2. By Route of Administration
      7.3.3.2.3. By End User
  7.3.4. Italy Drug Delivery Devices Market Outlook
    7.3.4.1. Market Size & Forecast
      7.3.4.1.1. By Value
    7.3.4.2. Market Share & Forecast
      7.3.4.2.1. By Application
      7.3.4.2.2. By Route of Administration
      7.3.4.2.3. By End User
  7.3.5. Spain Drug Delivery Devices Market Outlook
    7.3.5.1. Market Size & Forecast
      7.3.5.1.1. By Value
    7.3.5.2. Market Share & Forecast
      7.3.5.2.1. By Application
      7.3.5.2.2. By Route of Administration
      7.3.5.2.3. By End User

8. ASIA PACIFIC DRUG DELIVERY DEVICES MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Application
  8.2.2. By Route of Administration
  8.2.3. By End User
  8.2.4. By Country
8.3. Asia Pacific: Country Analysis
  8.3.1. China Drug Delivery Devices Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Application
      8.3.1.2.2. By Route of Administration
      8.3.1.2.3. By End User
  8.3.2. India Drug Delivery Devices Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Application
      8.3.2.2.2. By Route of Administration
      8.3.2.2.3. By End User
  8.3.3. Japan Drug Delivery Devices Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Application
      8.3.3.2.2. By Route of Administration
      8.3.3.2.3. By End User
  8.3.4. South Korea Drug Delivery Devices Market Outlook
    8.3.4.1. Market Size & Forecast
      8.3.4.1.1. By Value
    8.3.4.2. Market Share & Forecast
      8.3.4.2.1. By Application
      8.3.4.2.2. By Route of Administration
      8.3.4.2.3. By End User
  8.3.5. Australia Drug Delivery Devices Market Outlook
    8.3.5.1. Market Size & Forecast
      8.3.5.1.1. By Value
    8.3.5.2. Market Share & Forecast
      8.3.5.2.1. By Application
      8.3.5.2.2. By Route of Administration
      8.3.5.2.3. By End User

9. MIDDLE EAST & AFRICA DRUG DELIVERY DEVICES MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Application
  9.2.2. By Route of Administration
  9.2.3. By End User
  9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
  9.3.1. Saudi Arabia Drug Delivery Devices Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Application
      9.3.1.2.2. By Route of Administration
      9.3.1.2.3. By End User
  9.3.2. UAE Drug Delivery Devices Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Application
      9.3.2.2.2. By Route of Administration
      9.3.2.2.3. By End User
  9.3.3. South Africa Drug Delivery Devices Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Application
      9.3.3.2.2. By Route of Administration
      9.3.3.2.3. By End User

10. SOUTH AMERICA DRUG DELIVERY DEVICES MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Application
  10.2.2. By Route of Administration
  10.2.3. By End User
  10.2.4. By Country
10.3. South America: Country Analysis
  10.3.1. Brazil Drug Delivery Devices Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Application
      10.3.1.2.2. By Route of Administration
      10.3.1.2.3. By End User
  10.3.2. Colombia Drug Delivery Devices Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Application
      10.3.2.2.2. By Route of Administration
      10.3.2.2.3. By End User
  10.3.3. Argentina Drug Delivery Devices Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Application
      10.3.3.2.2. By Route of Administration
      10.3.3.2.3. By End User

11. MARKET DYNAMICS

11.1. Drivers
11.2. Challenges

12. MARKET TRENDS & DEVELOPMENTS

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. GLOBAL DRUG DELIVERY DEVICES MARKET : SWOT ANALYSIS

14. PORTER'S FIVE FORCES ANALYSIS

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. COMPETITIVE LANDSCAPE

15.1. Pfizer Inc.
  15.1.1. Business Overview
  15.1.2. Products & Services
  15.1.3. Recent Developments
  15.1.4. Key Personnel
  15.1.5. SWOT Analysis
15.2. Novartis AG
15.3. F. Hoffmann-La Roche Ltd
15.4. Johnson and Johnson
15.5. Bayer AG
15.6. Becton, Dickinson and Company
15.7. Altaris Capital Partners, LLC
15.8. Holozymes Inc. (Antares Pharma Inc.)
15.9. GlaxoSmithKline PLC
15.10. Teva Pharmaceutical Industries Ltd

16. STRATEGIC RECOMMENDATIONS

17. ABOUT US & DISCLAIMER